PEX19 antibody (C-Term)

Catalog No. ABIN926758

Product Details anti-PEX19 Antibody

Target: PEX19 (Peroxisomal Biogenesis Factor 19 (PEX19))

Binding Specificity: C-Term

Reactivity: Human

Host: Rabbit

Clonality: Polyclonal

Conjugate: This PEX19 antibody is un-conjugated

Application: Western Blotting (WB)

Purification: Purified

Immunogen: PEX19 antibody was raised in rabbit using the C terminal of PEX19 as the immunogen

Application Details

Application Notes: Optimal conditions should be determined by the investigator.

Comment:

PEX19 Blocking Peptide, catalog no. 33R-10300, is also available for use as a blocking control in assays to test for specificity of this PEX19 antibody

Restrictions: For Research Use only

Handling

Format: Lyophilized

Concentration: Lot specific

Buffer: Lyophilized powder. Add 50 µL of distilled water. Final antibody concentration is 1 mg/mL in PBS buffer.

Handling Advice: Avoid repeated freeze/thaw cycles.

Storage: 4 °C/-20 °C

Storage Comment: Store at 4 °C, following reconstitution, aliquot and store at -20 °C.

Target Details for PEX19

Target: PEX19 (Peroxisomal Biogenesis Factor 19 (PEX19))

Alternative Name: PEX19 (PEX19 Products)

Synonyms: BEST:GH03076 antibody, CG5325 antibody, DmelPex19 antibody, Dmel\\CG5325 antibody, D1S2223E antibody, HK33 antibody, PBD12A antibody, PMP1 antibody, PMPI antibody, PXF antibody, PXMP1 antibody, Pxf antibody, PxF antibody, Peroxin-19 antibody, Peroxin 19 antibody, Peroxisomal farnesylated protein antibody, peroxisomal biogenesis factor 19 antibody, Pex19 antibody, Bm1_19905 antibody, PEX19 antibody

Background: This gene is necessary for early peroxisomal biogenesis. It acts both as a cytosolic chaperone and as an import receptor for peroxisomal membrane proteins (PMPs). Peroxins (PEXs) are proteins that are essential for the assembly of functional peroxisomes. The peroxisome biogenesis disorders (PBDs) are a group of genetically heterogeneous autosomal recessive, lethal diseases characterized by multiple defects in peroxisome function. These disorders have at least 14 complementation groups, with more than one phenotype being observed for some complementation groups. Although the clinical features of PBD patients vary, cells from all PBD patients exhibit a defect in the import of one or more classes of peroxisomal matrix proteins into the organelle. Defects in this gene are a cause of Zellweger syndrome (ZWS), as well as peroxisome biogenesis disorder complementation group 14 (PBD-CG14), which is also known as PBD-CGJ. Alternative splicing results in multiple transcript variants. Synonyms: Polyclonal PEX19 antibody, Anti-PEX19 antibody, peroxisomal biogenesis factor 19 antibody, D1S2223E antibody, FLJ55296 antibody, HK33 antibody, PMP1 antibody, PMPI antibody, PXF antibody, PXMP1 antibody.